These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 26560857

  • 1. Frequency of three prothrombotic polymorphisms among Syrian population: factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase C677T.
    Jarjour RA, Ammar S, Majdalawi R.
    Ann Hum Biol; 2017 Feb; 44(1):70-73. PubMed ID: 26560857
    [Abstract] [Full Text] [Related]

  • 2. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N.
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [Abstract] [Full Text] [Related]

  • 3. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.
    J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
    Eid SS, Rihani G.
    Clin Lab Sci; 2004 May; 17(4):200-2. PubMed ID: 15559724
    [Abstract] [Full Text] [Related]

  • 6. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS, Singh MP, Yadav R.
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [Abstract] [Full Text] [Related]

  • 7. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
    Almawi WY, Ameen G, Tamim H, Finan RR, Irani-Hakime N.
    J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
    [Abstract] [Full Text] [Related]

  • 8. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH, Bolaman Z, Yukselen V, Kadikoylu G, Karaoglul AO, Batun S.
    Hepatogastroenterology; 2007 Jun; 54(77):1438-42. PubMed ID: 17708272
    [Abstract] [Full Text] [Related]

  • 9. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
    Falvella FS, Cremolini C, Miceli R, Nichetti F, Cheli S, Antoniotti C, Infante G, Martinetti A, Marmorino F, Sottotetti E, Berenato R, Caporale M, Colombo A, de Braud F, Di Bartolomeo M, Clementi E, Loupakis F, Pietrantonio F.
    Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
    [Abstract] [Full Text] [Related]

  • 10. High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T.
    Hussein AS.
    J Thromb Thrombolysis; 2012 Oct; 34(3):383-7. PubMed ID: 22528331
    [Abstract] [Full Text] [Related]

  • 11. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
    Cattaneo M, Chantarangkul V, Taioli E, Santos JH, Tagliabue L.
    Thromb Res; 1999 Jan 01; 93(1):1-8. PubMed ID: 10065893
    [Abstract] [Full Text] [Related]

  • 12. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.
    Belhaj Nefissi R, Doggui R, Ouali F, Messaoud T, Gritli N.
    Hemoglobin; 2018 Mar 01; 42(2):96-102. PubMed ID: 30200836
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.
    Rahimi Z, Ghaderi M, Nagel RL, Muniz A.
    J Thromb Thrombolysis; 2008 Dec 01; 26(3):229-33. PubMed ID: 17982733
    [Abstract] [Full Text] [Related]

  • 14. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
    Kabukcu S, Keskin N, Keskin A, Atalay E.
    Clin Appl Thromb Hemost; 2007 Apr 01; 13(2):166-71. PubMed ID: 17456626
    [Abstract] [Full Text] [Related]

  • 15. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A, Egin Y, Cam R, Akar N.
    Ann Hematol; 2009 Jan 01; 88(1):73-6. PubMed ID: 18682947
    [Abstract] [Full Text] [Related]

  • 16. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
    Ben Salem-Berrabah O, Fekih-Mrissa N, N'siri B, Ben Hamida A, Benammar-Elgaaied A, Gritli N, Mrissa R.
    J Clin Neurosci; 2012 Sep 01; 19(9):1326-7. PubMed ID: 22721898
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.
    Aydin H, Gunay M, Celik G, Gunay BO, Aydin UT, Karaman A.
    Ophthalmic Genet; 2016 Dec 01; 37(4):415-418. PubMed ID: 27018927
    [Abstract] [Full Text] [Related]

  • 18. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
    Ozmen F, Ozmen MM, Ozalp N, Akar N.
    Ulus Travma Acil Cerrahi Derg; 2009 Mar 01; 15(2):113-9. PubMed ID: 19353312
    [Abstract] [Full Text] [Related]

  • 19. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
    Rahimi Z, Mozafari H, Bigvand AH, Doulabi RM, Vaisi-Raygani A, Afshari D, Razazian N, Rezaei M.
    Clin Appl Thromb Hemost; 2010 Aug 01; 16(4):430-4. PubMed ID: 19703820
    [Abstract] [Full Text] [Related]

  • 20. Genetic and acquired prothrombotic risk factors and sudden hearing loss.
    Capaccio P, Ottaviani F, Cuccarini V, Bottero A, Schindler A, Cesana BM, Censuales S, Pignataro L.
    Laryngoscope; 2007 Mar 01; 117(3):547-51. PubMed ID: 17334320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.